125 related articles for article (PubMed ID: 17254776)
21. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
Raval-Pandya M; Freedman LP; Li H; Christakos S
Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
[TBL] [Abstract][Full Text] [Related]
22. The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression.
Campbell MJ; Gombart AF; Kwok SH; Park S; Koeffler HP
Oncogene; 2000 Oct; 19(44):5091-7. PubMed ID: 11042697
[TBL] [Abstract][Full Text] [Related]
23. Superagonistic action of 14-epi-analogs of 1,25-dihydroxyvitamin D explained by vitamin D receptor-coactivator interaction.
Eelen G; Verlinden L; Rochel N; Claessens F; De Clercq P; Vandewalle M; Tocchini-Valentini G; Moras D; Bouillon R; Verstuyf A
Mol Pharmacol; 2005 May; 67(5):1566-73. PubMed ID: 15728261
[TBL] [Abstract][Full Text] [Related]
24. Mammary-specific ablation of Cyp24a1 inhibits development, reduces proliferation and increases sensitivity to vitamin D.
Sheng L; Turner AG; Barratt K; Kremer R; Morris HA; Callen DF; Anderson PH; Tarulli GA
J Steroid Biochem Mol Biol; 2019 May; 189():240-247. PubMed ID: 30654105
[TBL] [Abstract][Full Text] [Related]
25. Vitamin D receptor (VDR) ablation alters carcinogen-induced tumorigenesis in mammary gland, epidermis and lymphoid tissues.
Zinser GM; Suckow M; Welsh J
J Steroid Biochem Mol Biol; 2005 Oct; 97(1-2):153-64. PubMed ID: 16111884
[TBL] [Abstract][Full Text] [Related]
26. Insulin-like growth factor binding protein-5 interacts with the vitamin D receptor and modulates the vitamin D response in osteoblasts.
Schedlich LJ; Muthukaruppan A; O'Han MK; Baxter RC
Mol Endocrinol; 2007 Oct; 21(10):2378-90. PubMed ID: 17595320
[TBL] [Abstract][Full Text] [Related]
27. Interplay between progesterone and prolactin in mammary development and implications for breast cancer.
Lee HJ; Ormandy CJ
Mol Cell Endocrinol; 2012 Jun; 357(1-2):101-7. PubMed ID: 21945475
[TBL] [Abstract][Full Text] [Related]
28. The impact of vitamin D in breast cancer: genomics, pathways, metabolism.
Narvaez CJ; Matthews D; LaPorta E; Simmons KM; Beaudin S; Welsh J
Front Physiol; 2014; 5():213. PubMed ID: 24982636
[TBL] [Abstract][Full Text] [Related]
29. Hereditary vitamin D resistant rickets caused by a novel mutation in the vitamin D receptor that results in decreased affinity for hormone and cellular hyporesponsiveness.
Malloy PJ; Eccleshall TR; Gross C; Van Maldergem L; Bouillon R; Feldman D
J Clin Invest; 1997 Jan; 99(2):297-304. PubMed ID: 9005998
[TBL] [Abstract][Full Text] [Related]
30. Signature of VDR miRNAs and epigenetic modulation of vitamin D signaling in melanoma cell lines.
Essa S; Reichrath S; Mahlknecht U; Montenarh M; Vogt T; Reichrath J
Anticancer Res; 2012 Jan; 32(1):383-9. PubMed ID: 22213330
[TBL] [Abstract][Full Text] [Related]
31. Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells.
Sertznig P; Dunlop T; Seifert M; Tilgen W; Reichrath J
Anticancer Res; 2009 Sep; 29(9):3647-58. PubMed ID: 19667161
[TBL] [Abstract][Full Text] [Related]
32. Vitamin D and cellular Ca2+ signaling in breast cancer.
Sergeev IN
Anticancer Res; 2012 Jan; 32(1):299-302. PubMed ID: 22213319
[TBL] [Abstract][Full Text] [Related]
33. Integrins in mammary development.
Raymond K; Faraldo MM; Deugnier MA; Glukhova MA
Semin Cell Dev Biol; 2012 Jul; 23(5):599-605. PubMed ID: 22430758
[TBL] [Abstract][Full Text] [Related]
34. Specificity of steroid binding in New World primate B95-8 cells with a vitamin D-resistant phenotype.
Gacad MA; Adams JS
Endocrinology; 1992 Dec; 131(6):2581-7. PubMed ID: 1446602
[TBL] [Abstract][Full Text] [Related]
35. Vitamin D in normal and pathological parathyroid glands: new prospects for treating hyperparathyroidism (review).
Buchwald PC; Westin G; Akerström G
Int J Mol Med; 2005 Apr; 15(4):701-6. PubMed ID: 15754035
[TBL] [Abstract][Full Text] [Related]
36. A-ring analogues of 1, 25-(OH)2D3 with low affinity for the vitamin D receptor modulate chondrocytes via membrane effects that are dependent on cell maturation.
Greising DM; Schwartz Z; Posner GH; Sylvia VL; Dean DD; Boyan BD
J Cell Physiol; 1997 Jun; 171(3):357-67. PubMed ID: 9180905
[TBL] [Abstract][Full Text] [Related]
37. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
Murthy S; Agoulnik IU; Weigel NL
Prostate; 2005 Sep; 64(4):362-72. PubMed ID: 15754350
[TBL] [Abstract][Full Text] [Related]
38. Vitamin D/VDR signaling pathway ameliorates 2,4,6-trinitrobenzene sulfonic acid-induced colitis by inhibiting intestinal epithelial apoptosis.
Zhu T; Liu TJ; Shi YY; Zhao Q
Int J Mol Med; 2015 May; 35(5):1213-8. PubMed ID: 25813397
[TBL] [Abstract][Full Text] [Related]
39. Autocrine TGFbeta signaling mediates vitamin D3 analog-induced growth inhibition in breast cells.
Yang L; Yang J; Venkateswarlu S; Ko T; Brattain MG
J Cell Physiol; 2001 Sep; 188(3):383-93. PubMed ID: 11473365
[TBL] [Abstract][Full Text] [Related]
40. Chemoprevention of chemically-induced mammary and colon carcinogenesis by 1alpha-hydroxyvitamin D5.
Murillo G; Mehta RG
J Steroid Biochem Mol Biol; 2005 Oct; 97(1-2):129-36. PubMed ID: 16051482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
